An association between protein glycosylation and tumorigenesis has been rec
ognized for over 10 years. Associations linking the importance of glycosyla
tion events to tumor biology, especially the progression to metastatic dise
ase, have been noted over many years, Recently, a mouse model in which beta
1,6-N-acetylglucosaminyltransferase V (a rate-limiting enzyme in the N-glyc
an pathway) has been knocked out, was used to demonstrate the importance of
glycosylation in tumor progression. By crossing mice lacking this enzyme w
ith a transgenic mouse model of metastatic breast cancer, metastatic progre
ssion of the disease was dramatically reduced. These experiments provide in
vivo evidence for the role of N-linked glycosylation in metastatic breast
cancer and have significant implications for the development of new treatme
nt strategies.